MA50443A - Modulateurs agonistes de récepteurs de glucocorticoïdes sélectifs (segrams) non stéroïdiens et leurs utilisations - Google Patents

Modulateurs agonistes de récepteurs de glucocorticoïdes sélectifs (segrams) non stéroïdiens et leurs utilisations

Info

Publication number
MA50443A
MA50443A MA050443A MA50443A MA50443A MA 50443 A MA50443 A MA 50443A MA 050443 A MA050443 A MA 050443A MA 50443 A MA50443 A MA 50443A MA 50443 A MA50443 A MA 50443A
Authority
MA
Morocco
Prior art keywords
segrams
steroid
receptor agonist
glucocorticoid receptor
selective glucocorticoid
Prior art date
Application number
MA050443A
Other languages
English (en)
Inventor
Pierre Chambon
Guoqiang Hua
Original Assignee
Association Pour La Rech A Ligbmc Ari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Association Pour La Rech A Ligbmc Ari filed Critical Association Pour La Rech A Ligbmc Ari
Publication of MA50443A publication Critical patent/MA50443A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA050443A 2017-10-27 2018-10-23 Modulateurs agonistes de récepteurs de glucocorticoïdes sélectifs (segrams) non stéroïdiens et leurs utilisations MA50443A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762578036P 2017-10-27 2017-10-27
EP18305612.6A EP3569228A1 (fr) 2018-05-17 2018-05-17 Modulateurs agonistes de récepteurs de glucocorticoïdes sélectifs (segrams) non stéroïdiens et leurs utilisations

Publications (1)

Publication Number Publication Date
MA50443A true MA50443A (fr) 2020-09-02

Family

ID=62386318

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050443A MA50443A (fr) 2017-10-27 2018-10-23 Modulateurs agonistes de récepteurs de glucocorticoïdes sélectifs (segrams) non stéroïdiens et leurs utilisations

Country Status (9)

Country Link
US (1) US11179363B2 (fr)
EP (2) EP3569228A1 (fr)
JP (1) JP2021509411A (fr)
KR (1) KR20200085782A (fr)
CN (1) CN111511359A (fr)
AU (1) AU2018355698A1 (fr)
BR (1) BR112020008350A2 (fr)
MA (1) MA50443A (fr)
PT (1) PT3700513T (fr)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262165A (en) 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US6010715A (en) 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
UA48973C2 (uk) 1995-06-07 2002-09-16 Орто-Макнейл Фармасьютікалз Інк. Трансдермальний пластир на основі 17-деацетилноргестимату для попередження овуляції
DE19723722A1 (de) * 1997-05-30 1998-12-10 Schering Ag Nichtsteroidale Gestagene
US6245804B1 (en) 1997-05-30 2001-06-12 Schering Aktiengesellschaft Nonsteroidal gestagens
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
DE19856475A1 (de) * 1998-11-27 2000-05-31 Schering Ag Nichtsteroidale Entzündungshemmer
DE10038639A1 (de) * 2000-07-28 2002-02-21 Schering Ag Nichtsteroidale Entzündungshemmer
FI3700513T3 (fi) * 2017-10-27 2022-12-15 Ei-steroidiset selektiiviset glukortikoidireseptorin agonistimodulaattorit (segramit) ja niiden käyttö

Also Published As

Publication number Publication date
EP3700513B1 (fr) 2022-08-24
PT3700513T (pt) 2022-11-30
US20210177798A1 (en) 2021-06-17
CN111511359A (zh) 2020-08-07
KR20200085782A (ko) 2020-07-15
AU2018355698A1 (en) 2020-05-14
EP3569228A1 (fr) 2019-11-20
US11179363B2 (en) 2021-11-23
BR112020008350A2 (pt) 2020-11-03
EP3700513A2 (fr) 2020-09-02
JP2021509411A (ja) 2021-03-25

Similar Documents

Publication Publication Date Title
MA56480A (fr) Agonistes du récepteur glp-1 et leurs utilisations
MA54555A (fr) Agonistes de glp-1r et leurs utilisations
DK3596053T3 (da) Farnesoid-x-receptoragonister og anvendelser deraf
MA50502A (fr) Adénovirus et utilisations associées
DK3464318T3 (da) Glucocorticoidreceptoragonist og immunkonjugater deraf
MA52414A (fr) Anticorps agonistes de pd-1 et leurs utilisations
MA41460A (fr) Agents de liaison à la tnfrsf et leurs utilisations
MA49687A (fr) Anticorps anti-ctla-4 et leurs utilisations
MA49537A (fr) Anticorps anti-lag3 et leurs utilisations
MA47789A (fr) Anticorps anti-phf-tau et leurs utilisations
DK3490565T3 (da) Azetidinderivater som chemokinreceptormodulatorer og anvendelser deraf
DK3350165T3 (da) Farnesoid-X-receptoragonister og anvendelser deraf
MA43417A (fr) Agonistes améliorés du récepteur de l'apéline (apj) et leurs utilisations
MA42622A (fr) Agents de liaison à tigit et leurs utilisations
MA50144A (fr) Anticorps anti-peptides bêta-amyloïdes n3pglu et utilisations associées
MA49823A (fr) Anticorps dirigés contre pd-l1
MA53400A (fr) Hétéromultimères alk7: actriib et leurs utilisations
MA53837A (fr) Tetrahydro-pyrido[3,4-b]indoles modulateurs des récepteurs des oestrogènes et leurs utilisations
MA53665A (fr) Agonistes du récepteur farnésoïde x et leurs utilisations
DK3591944T3 (da) Anycast-baseret wide area-system til distribueret allokering og belastningsbalancering
MA49565A (fr) Anticorps agonistes qui lient cd137 humain et leurs utilisations
MA45125A (fr) Anticorps anti-alpha-synucléine et leurs utilisations
MA49886A (fr) Anticorps anti-par2 et leurs utilisations
MA43567A (fr) Anticorps pacap et leurs utilisations
DK3658192T3 (da) Glucocorticoid-receptoragonist og immunokonjugater deraf